Proteinase-Activated Receptors in Fibroproliferative Lung Disease

Thorax - United Kingdom
doi 10.1136/thoraxjnl-2013-204367
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Basic and Translational Research on Proteinase-Activated Receptors: Implication of Proteinase/Proteinase-Activated Receptor in Gastrointestinal Inflammation

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2008English

Proteinase-Activated Receptors, Targets for Kallikrein Signaling

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Proteinase-Activated Receptors (PARs) as Targets for Antiplatelet Therapy

Biochemical Society Transactions
Biochemistry
2016English

Proteinase-Activated Receptors (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

IUPHAR/BPS Guide to Pharmacology CITE
2019English

Potential of Proteinase-Activated Receptors as a Novel Target for Treatment of Pulmonary Hypertension

Folia Pharmacologica Japonica
Pharmacology
2014English

Novel Role for Proteinase-Activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-Activated Receptor 4 (PAR4)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2012English

Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2002English

Physiology and Pathophysiology of Proteinase-Activated Receptors (PARs): Role of Tryptase/Par-2 in Vascular Endothelial Barrier Function

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2005English

Peroxisome Proliferator-Activated Receptors Associated With Nonalcoholic Fatty Liver Disease

PPAR Research
Drug DiscoveryPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy